Satoru Hagihara

J-GLOBAL         Last updated: Oct 18, 2019 at 10:53
 
Avatar
Name
Satoru Hagihara
Affiliation
Kindai University
Section
Faculty of Medicine

Research Areas

 
 

Published Papers

 
Hagiwara S, Nishida N, Ida H, Ueshima K, Minami Y, Takita M, Komeda Y, Kudo M
Journal of medical virology      Jun 2019   [Refereed]
Hagiwara S, Nishida N, Watanabe T, Ida H, Sakurai T, Ueshima K, Takita M, Komeda Y, Nishijima N, Osaki Y, Kudo M
Antiviral therapy   23(6) 513-521   Feb 2018   [Refereed]
Yamao K, Takenaka M, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Hagiwara S, Sakurai T, Nishida N, Chiba Y, Watanabe T, Kudo M
Internal medicine (Tokyo, Japan)      Apr 2019   [Refereed]
Kono M, Sakurai T, Okamoto K, Nagai T, Komeda Y, Kashida H, Minaga K, Kamata K, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Enoki E, Inoue H, Matsumura I, Kudo M
Internal medicine (Tokyo, Japan)      Apr 2019   [Refereed]
Komeda Y, Watanabe T, Sakurai T, Kono M, Okamoto K, Nagai T, Takenaka M, Hagiwara S, Matsui S, Nishida N, Tsuji N, Kashida H, Kudo M
World journal of gastroenterology   25(12) 1502-1512   Mar 2019   [Refereed]
Sakurai T, Komeda Y, Nagai T, Kamata K, Minaga K, Yamao K, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Kashida H, Nakagawa K, Kudo M
Digestion   1-9   Dec 2018   [Refereed]
Nishida N, Nishimura T, Kaido T, Minaga K, Yamao K, Kamata K, Takenaka M, Ida H, Hagiwara S, Minami Y, Sakurai T, Watanabe T, Kudo M
Cancers   10(10)    Sep 2018   [Refereed]
Kono M, Komeda Y, Sakurai T, Okamoto A, Minaga K, Kamata K, Hagiwara S, Inoue H, Enoki E, Matsumura I, Watanabe T, Kudo M
Journal of Crohn's & colitis   12(4) 499-502   Mar 2018   [Refereed]
Okamoto K, Watanabe T, Komeda Y, Okamoto A, Minaga K, Kamata K, Yamao K, Takenaka M, Hagiwara S, Sakurai T, Tanaka T, Sakamoto H, Fujimoto K, Nishida N, Kudo M
Frontiers in immunology   9 918   2018   [Refereed]
Yoshida A, Hagiwara S, Watanabe T, Nishida N, Ida H, Sakurai T, Komeda Y, Yamao K, Takenaka M, Enoki E, Kimura M, Miyake M, Kawada A, Kudo M
Internal medicine (Tokyo, Japan)   57(17) 2505-2509   2018   [Refereed]
Sakurai T, Yada N, Hagiwara S, Arizumi T, Minaga K, Kamata K, Takenaka M, Minami Y, Watanabe T, Nishida N, Kudo M
Cancer Sci   108(10) 1996-2003   Oct 2017   [Refereed]
Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis
Hagiwara S, Nishida N, Park AM, Komeda Y, Sakurai T, Watanabe T, Kudo M
Sci Rep   7(1) 10440   Sep 2017   [Refereed]
Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C
Umehara Y, Hagiwara S, Nishida N, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Chishina H, Ueshima K, Komeda Y, Arizumi T, Watanabe T, Kudo M
Dig Dis   35(6) 548-555   2017   [Refereed]
Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
Kono M, Nishida N, Hagiwara S, Minami T, Chishina H, Arizumi T, Minaga K, Kamata K, Komeda Y, Sakurai T, Takenaka M, Takita M, Yada N, Ida H, Minami Y, Ueshima K, Watanabe T, Kudo M
Dig Dis   35(6) 556-564   2017   [Refereed]
Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection
Ida H, Hagiwara S, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Minami Y, Ueshima K, Nishida N, Kudo M
Dig Dis   35(6) 565-573   2017   [Refereed]
Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2
Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M
Dig Dis   35(6) 583-588   2017   [Refereed]
Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2
Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M
Dig Dis   35(6) 589-597   2017   [Refereed]
Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma
Minami Y, Minami T, Hagiwara S, Ida H, Ueshima K, Nishida N, Murakami T, Kudo M
Eur Radiol   1-8   2017   [Refereed]
Computer-Aided Diagnosis Based on Convolutional Neural Network System for Colorectal Polyp Classification: Preliminary Experience
Komeda Y, Handa H, Watanabe T, Nomura T, Kitahashi M, Sakurai T, Okamoto A, Minami T, Kono M, Arizumi T, Takenaka M, Hagiwara S, Matsui S, Nishida N, Kashida H, Kudo M
Oncology   93 30-34   2017   [Refereed]
Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification
Komeda Y, Kashida H, Sakurai T, Asakuma Y, Tribonias G, Nagai T, Kono M, Minaga K, Takenaka M, Arizumi T, Hagiwara S, Matsui S, Watanabe T, Nishida N, Chikugo T, Chiba Y, Kudo M
Oncology   93 49-54   2017   [Refereed]
Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy
Sakurai T, Adachi T, Kono M, Arizumi T, Kamata K, Minaga K, Yamao K, Komeda Y, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Kashida H, Kudo M
Oncology   93 27-29   2017   [Refereed]
Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease
Yamada M, Sakurai T, Komeda Y, Nagai T, Kamata K, Minaga K, Yamao K, Takenaka M, Hagiwara S, Matsui S, Watanabe T, Nishida N, Kashida H, Kudo M
Oncology   93 20-26   2017   [Refereed]
Serum microRNA profile that predict initial effect of sorafenib in patients with advanced hepatocellular carcinoma
Nishida N, Arizumi T, Hagiwara S, Ida H, Sakurai T, Kudo M
Liver Cancer   6 113-125   2017   [Refereed]
The overall survival of patients with hepatocellular carcinoma correlates with the newly defined time to progression after transarterial chemoembolization
Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M
Liver Cancer   6 227-235   2017   [Refereed]
A case of type II enteropathy-associated T-Cell lymphoma in a patient with ulcerativecolitis
Komeda Y, Kashida H, Sakurai T, Kono M, Nagai T, Asakuma Y, Hagiwara S, Matsui S, Watanabe T, Chikugo T, Kudo M
Am J Gastroenterol   112 833   2017   [Refereed]
The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
Sakurai T, Higashitsuji H, Kashida H, Watanabe T, Komeda Y, Nagai T, Hagiwara S, Kitano M, Nishida N, Abe T, Kiyonari H, Ithoh K, Fujita J, Kudo M
Oncotarget   8 24762-24776   2017   [Refereed]
Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-α and IL-33 produced by plasmacytoid dendritic cells
Watanabe T, Yamashita K, Arai Y, Minaga K, Kamata K, Nagai T, Komeda Y, Takenaka M, Hagiwara S, Ida H, Sakurai T, Nishida N, Strober W, Kudo M
J Immunol   198 3886-3896   2017   [Refereed]
Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Ueshima K, Komeda Y, Arizumi T, Kudo M
Oncology   92 3-9   2017   [Refereed]
Kwok WY, Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Kono M, Ueshima K, Komeda Y, Arizumi T, Enoki E, Nakai T, Kumabe T, Nakashima O, Kondo F, Kudo M
Oncology 9   92 16-28   2017   [Refereed]
Kono M, Minami Y, Iwanishi M, Minami T, Chishina H, Arizumi T, Komeda Y, Sakurai T, Takita M, Yada N, Ida H, Hagiwara S, Ueshima K, Nishida N, Kudo M
Oncology   92 29-34   2017   [Refereed]
Removal of diminutive colorectal polyps: a prospective randomized clinical trial between cold snare polypectomy and hot forceps biopsy
Komeda Y, Kashida H, Sakurai T, Tribonias G, Okamoto K, Kono M, Yamada M, Adachi T, Mine H, Nagai T, Asakuma Y, Hagiwara S, Matsui S, Watanabe T, Kitano M, Chikugo T, Chiba Y, Kudo M
World J Gastroenterol   23 328-335   2017   [Refereed]
MicroRNAs for the prediction of early response to sorafenib treatment in human hepatocellular carcinoma
Nishida N, Arizumi T, Hagiwara S, Ida H, Sakurai T, Kudo M
Liver Cancer   6 113-125   2017   [Refereed]
Stress response protein RBM3 promotes the development of colitis-associated cancer
Sakurai T, Kashida H, Komeda Y, Nagai T, Hagiwara S, Watanabe T, Kitano M, Nishida N, Fujita J, Kudo M
Inflamm Bowel Dis   23 66-74   2017   [Refereed]
Hagiwara S, Nishida N, Chishina H, Ida H, Sakurai T, Komeda Y, Kitano M, Kudo M
Intern Med   55 3273-3277   2016   [Refereed]
Reply: Hepatocyte damage due to protoporphyrin deposition
Hagiwara S, Nishida N, Kudo M
Hepatology   64 306   2016   [Refereed]
Nishida N, Yada N, Hagiwara S, Sakurai T, Kitano M, Kudo M
J Gastroen Hepatol   31 1646-1653   2016   [Refereed]
Nagai T, Arao T, Nishio K, Matsumoto K, Hagiwara S, Sakurai T, Minami Y, Ida H, Ueshima K, Nishida N, Sakai K, Saijo N, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Haji S, Kudo M
Digest Dis   34 702-707   2016   [Refereed]
Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ida H, Sakurai T, Kitano M, Nishida N, Kudo M
Digest Dis   34 671-678   2016   [Refereed]
Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M
Digest Dis   34 650-653   2016   [Refereed]
Minami Y, Minami T, Chishina H, Kono M, Arizumi T, Takita M, Yada N, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M
Digest Dis   34 687-691   2016   [Refereed]
Chishina H, Hagiwara S, Nishida N, Ueshima K, Sakurai T, Ida H, Minami Y, Takita M, Kono M, Minami T, Iwanishi M, Umehara Y, Watanabe T, Komeda Y, Arizumi T, Kudo M
Digest Dis   34 659-664   2016   [Refereed]
Takita M, Iwanishi M, Minami T, Kono M, Chishina K, Arizumi T, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Nishida N, Kudo M
Digest Dis   34 654-658   2016   [Refereed]
Nishida N, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Ida H, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kudo M
Digest Dis   34 632-639   2016   [Refereed]
Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Ueshima K, Komeda Y, Arizumi T, Kudo M
Digest Dis   34 620-626   2016   [Refereed]
Hagiwara S, Nishida N, Kudo M
Hepatology   63 1744-1745   2016   [Refereed]
Hagiwara S, Nishida N, Park AM, Sakurai T, Kawada A, Kudo M
Hepatology   62 1638-1689   2015   [Refereed]
Effectiveness of sorafenib in patients with transcatheter arterial chemoembolization (TACE) refractory and intermediate-stage hepatocellular carcinoma
Arizumi T, Ueshima K, Minami T, Kono M, Chishina H, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M
Liver Cancer   4 253-262   2015   [Refereed]
Phase I/II study of sorafenib in combination with hepatic arterial infusion chemotherapy using low-dose cisplatin and 5-fluorouracil
Ueshima K, Kudo M, Tanaka M, Kumada T, Chung H, Hagiwara S, Inoue T, Yada N, Kitai S
Liver Cancer   4 263-273   2015   [Refereed]
Hagiwara S, Nishida N, Kudo M
World J Hepatol   7 2427-2431   2015   [Refereed]
Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ueshima K, Ida H, Nishida N, Kudo M
Oncology   89 53-59   2015   [Refereed]

Misc

 
ARIZUMI Tadaaki, UESHIMA Kazuomi, TAKEDA Haruhiko, OSAKI Yukio, HAGIWARA Satoru, INOUE Tatsuo, KITAI Satoshi, YADA Norihisa, SAKURAI Toshiharu, NISHIDA Naoshi, KUDO Masatoshi
Kanzo   53(6) 344-347   Jun 2012
Response Evaluation Criteria In Solid Tumor version 1.1 (RECIST1.1), modified RECIST (mRECIST) and Response Evaluation Criteria In Cancer of the Liver (RECICL) are frequently used as a response evaluation criteria for hepatocellular carcinoma. The...
ARIZUMI Tadaaki, UESHIMA Kazuomi, HAYAISHI Sousuke, TAKITA Masahiro, KITAI Satoshi, INOUE Tatsuo, YADA Norihisa, HAGIWARA Satoru, MINAMI Yasunori, SAKURAI Toshiharu, NISHIDA Naoshi, KUDO Masatoshi
Kanzo   53(6) 348-350   Jun 2012
【PURPOSE】 Sorafenib is a molecularly-targeted drug, which have been proven survival benefit for advanced hepatocellular carcinoma (HCC). Because of the unique side effects of sorafenib such as hand-foot skin reaction (HFSR), the administration of ...
INUZUKA Tadashi, OSAKI Yukio, MATSUDA Fumihiro, SAKAMOTO Azusa, HATAMARU Keiichi, HENMI Shinichiro, ISHIKAWA Tetsuro, SAITO Sumio, NISHIKAWA Hiroki, KITA Ryuichi, OKABE Yoshihiro, KIMURA Toru, WAKASA Tomoko, HAGIWARA Satoru, KUDO Masatoshi
Kanzo   53(1) 42-47   Jan 2012
A 65-year-old Japanese male with chronic hepatitis B (CH-B) diagnosed in December 2008 was referred to our department in July 2009. He started combination therapy with peginterferon alfa-2b (80 μg/week) and entecavir (0.5 mg/day) for 48 weeks from...
HATANAKA Kinuyo, MINAMI Yasunori, KITAI Satoshi, TATSUMI Chie, TAKAHASHI Syunsuke, INOUE Tatsuo, HAGIWARA Satoru, CHUNG Hobyung, UESHIMA Kazuomi, KUDO Masatoshi
35    Apr 2008
INOUE Tatsuo, SAKAGUTI Yasuhiro, HAGIWARA Satoru, MINAMI Yasunori, TEI Hiroshi, UESHIMA Kazuomi, FUKUNAGA Toyokazu, MAEKAWA Kiyossi
32    Apr 2005

Conference Activities & Talks

 
Combination therapy with peginterferon and entecavir for persistent viral suppression in patients with chronic hepatitis B
Hagiwara S, Nishida N, Kudo M
23rd International Symposium on Hepatitis C Virus and Related Viruses (HCV2016)   11 Oct 2016   
Pathological feature, oxidative DNA damage and epigenetic alteration of tumor suppressor genes in nonalcoholic fatty liver disease
Nishida N, Yada N, Chishina H, Arizumi T, Takita M, Kitai S, Inoue T, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kudo M
65th Annual Meeting, American Association for the Study of Liver Diseases (AASLD2014)   7 Nov 2014   
The retrospective study of novel anticancer agent, miriplatin in TACE and TAI for unresectable hepatocellular carcinoma in Japan
Nagai N, Ueshima K, Hayaishi S, Takita M, Kitai S, Yada N, Inoue T, Hagiwara S, Minami Y, Nishida N, Kudo M
Asian Pacific Digestive Week (APDW) 2012   5 Dec 2012   
Value of liver parenchymal phase imaging of contrast-enhanced ultrasonography to diagnose the premalignant/borderline lesions and overt HCC
Inoue T, Kudo M, Hatanaka K, Takahashi S, Kitai S, Ueda D, Hagiwara S, Minami Y, Chung H, Ueshima K
16th United Europian Gastroenterology Week(UEGW)   18 Oct 2008   
Qualitative and quantitative analysis of liver-parenchymal phase contrast-enhanced US with Sonazoid in detecting HCC; Comparison with SPIO-MRI.
16th United Europian Gastroenterology Week(UEGW)   Oct 2008   16th United Europian Gastroenterology Week(UEGW)
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+PEG-IFN α-2b therapy against advanced hepatocellular carcinoma
The 60th Annual Meeting of the American Association for the study of liver diseases (AASLD)   Nov 2009   The 60th Annual Meeting of the American Association for the study of liver diseases (AASLD)
The usefulness of the post-vascular phase of contrast-enhanced ultrasonography with Sonazoid in the evaluation of gross type of hepatocellular carcinoma.
Hatanaka K, Chung H, Kudo M, Kitai S, Inoue T, Yada N, Hagiwara S, Ueshima K
American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2010   29 Oct 2010   American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2010
Usefulness of hepatocyte phase imaging of Gd-EOB-DTPA-MRI in detecting borderline lesions which are difficult to detect other imaging modalities.
18th United European Gastroenterology Week (UEGW) 2010   Oct 2010   18th United European Gastroenterology Week (UEGW) 2010
Can Gd-EOB-DTPA-enhanced MRI discriminate between dysplastic nodules and early-to- well-differentiated HCC?
18th United European Gastroenterology Week (UEGW) 2010   Oct 2010   18th United European Gastroenterology Week (UEGW) 2010
Expression levels of EMT-related genes in hepatocellular carcinoma.
AACR 102th Annual Meeting 2011   Apr 2011   AACR 102th Annual Meeting 2011
Phase I study of Sorafenib in combination with low-dose cisplatin and flurouracil intra-arterilal infusion chemotherapy.
International Liver Cancer Association Fifth Annual Conference (ILCA) 2011   Sep 2011   International Liver Cancer Association Fifth Annual Conference (ILCA) 2011
Impact of TJP-1 and TWIST expression on post-operative prognosis in hepatocellular carcinoma.
70th Annual Meeting of the Japanese Cancer Association   Oct 2011   70th Annual Meeting of the Japanese Cancer Association
Phase I study of Sorafenib in combination with low-dose cisplatin and fluorouracil intra-arterial infusion chemotherapy.
The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)   Nov 2011   The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Assessment of hepatobiliary phase Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection ability versus MDCT.
The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)   Nov 2011   The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Prognostic impact of EMT-related genes on post-operative prognosis in hepatocellular carcinoma.
AACR 103rd Annual Meeting 2011   Mar 2012   AACR 103rd Annual Meeting 2011
Novel association between global DNA hypomethylation and chromosomal instability phenotype in human hepatocellular carcinoma
Digestive Disease Week(DDW) 2012   May 2012   Digestive Disease Week(DDW) 2012
Activation of JNK in the Non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma
Digestive Disease Week(DDW) 2012   May 2012   Digestive Disease Week(DDW) 2012
The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced sonography using perfluorocarbon microbubbles (sonazoid)
Digestive Disease Week(DDW) 2012   May 2012   Digestive Disease Week(DDW) 2012
Usefulness of contrast-enhanced ultrasonography to evaluate a post treatment effect of radiofrequentry ablation about hepatocellular carcinoma: comparison with contrast-enhanced CT
Digestive Disease Week(DDW) 2012   May 2012   Digestive Disease Week(DDW) 2012
Noninvasive assessment of liver fibrosis by measurement of LF index in patients with chronic viral hepatitis.
Digestive Disease Week(DDW) 2013   May 2013   Digestive Disease Week(DDW) 2013
Heat shock protein 27 expression is inversely correlated with intraepithelial neoplasia and positively correlated with poor differentiation of gastris cancer.
Digestive Disease Week(DDW) 2013   May 2013   Digestive Disease Week(DDW) 2013
Unique association between global dna hypomethylation and chromosomal alterations in human hepatocellular carcinoma.
Seventh Annual Conference International Liver Cancer Asso-ciation(ILCA)   Sep 2013   Seventh Annual Conference International Liver Cancer Asso-ciation(ILCA)
Sorafenib treatment for non-hypervascular hepatocellular carcinoma
Seventh Annual Conference International Liver Cancer Association (ILCA)   Sep 2013   Seventh Annual Conference International Liver Cancer Association (ILCA)
Role of oxidative stress and epigenetic alteration on chronic hepatitis C-related human hepatocarcinogenesis
The 64th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)   Nov 2013   The 64th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
Regulatory failure of serum prohepcidin levels in patients with hepatitis C
Nagashima M, Kudo M, Chung H, Ishikawa E, Hagiwara S, Nakatani T
DDW (Digestive Disease Week) and the 108th Annual Meeting of the AGA   19 May 2007   
Regulatory failure of serum prohepcidin levels in patients with hepatitis C
Nagashima M, Kudo M, Chung H, Ishikawa E, Hagiwara S, Nakatani T
17th APASL Conference   27 Mar 2007   
Carcinogenic risk factors in hepatitis B rivus infection
Hagiwara S, Nakatani T, Minami Y,Chung H, Ueshima K, Fukunaga T, Kudo M, Munakata H
41th Annual Meeting of the European Association for the Study of the Liver (EASL)   26 Apr 2006   
Comparison of staging systems for hepatocellular carcinoma in Japanese cohort
Chung H, Takahashi S, Minami Y, Inoue T, Sakaguchi Y, Hagiwara S, Fukunaga T, Ueshima K, Kudo M
41th Annual Meeting of the European Association for the Study of the Liver (EASL)   26 Apr 2006   
Real-time virtual sonography, an integrated system of computer tomography with ultrasound images: value in radiofrequency ablation guidance
Minami Y, Chung H, Inoue T, Hagiwara S, Hatanaka K, Sakaguchi Y, Ueshima K, Fukunaga T, Kudo M
15th Asian Pacific Association for the Study of the Liver (APASL)   20 Aug 2005   
Evaluation of therapeutic response to gemcitabine in pancreatic cancers: value of contrast-enhanced harmonic ultrasonography
Sakamoto H, Kitano M, Suetomi Y, Fukuta N, Inoue T, Sakaguchi Y, Umehara Y, Hagiwara S, Ichikawa T, Hatanaka K, Kudo M
12th United European Gastroenterology Week (UEGW)   25 Sep 2004